Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Eurofins Genomics Opens Louisville Facility
Thursday, March 03, 2016
Company has announced the opening of its new manufacturing and services facility for the custom production of DNA and RNA oligonucleotides synthetic gene synthesis, and genomics services.

Illuminating the Broad Spectrum of Disease
Wednesday, March 02, 2016
PRISM efficiently tests drug compounds in multiple cell lines simultaneously, accelerating discovery of targeted therapies in the service of precision medicine.

AGBT: Going Beyond Sequencing
Thursday, February 25, 2016
Advances in Genome Biology and Technology 2016 saw a strong focus on the workflow: 'sample in, insight out'.

Illumina Applies CE Mark to VeriSeq™ NIPT Analysis Software
Thursday, February 25, 2016
Company has announced that it has applied the CE mark to expand the use of VeriSeq NIPT analysis software in clinical laboratories.

Illumina Sues Oxford Nanopore for Patent Infringement
Wednesday, February 24, 2016
Illumina, Inc. has announced that the company filed lawsuits against Oxford Nanopore Technologies Ltd. and Oxford Nanopore Technologies, Inc. (ONT).

Macrogen, Silicon Biosystems Partner
Tuesday, February 23, 2016
Company has announced the collaboration for development of clinical tests utilizing high-throughput Next Generation Sequencing capabilities.

LGC Named as a Centre of Expertise for Food Authenticity Testing
Monday, February 22, 2016
Company recognised as a Centre of Expertise for food authenticity testing in the UK and listed on the Virtual Food Authenticity Network.

New Approach Identifies Genetic Risk Factors for Complex Human Diseases
Monday, February 22, 2016
New mathematical model explains variability in mutation rates across the human genome.

Thermo, Children’s Hospital Los Angeles Partner
Friday, February 19, 2016
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA’s first NGS panel designed to target biomarkers associated with childhood cancers.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 829
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!